Rare diseases
Investigational molecules
Locations
Vetenskapens Grand 11, Fassberg, 431 53 Molndal, Sweden
Ribocure Pharmaceuticals AB in Molndal, Sweden specialises in clinical trials of conditions such as Coronary artery disease, Dyslipidaemia, and other specialisations. This site conducts important research.
The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for conditions such as mixed dyslipidemia and stable coronary artery disease. Through rigorous clinical trials, the center is exploring new therapeutic avenues to improve patient outcomes.
By conducting trials like the evaluation of RBD5044 and RBD4059, the center is contributing significantly to the understanding and management of these complex cardiovascular conditions.
Clinical trials currently enrolling participants at this site.
Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness
SwedenSafety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease
SwedenStudy of RBD4059 and acetylsalicylic acid in patients with stable coronary artery disease: evaluation of safety and drug behavior in the body
SwedenMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
